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a-Neurexins are essential synaptic adhesion mole-
cules implicated in autism spectrum disorder and
schizophrenia. The a-neurexin extracellular domain
consists of six LNS domains interspersed by three
EGF-like repeats and interacts with many different
proteins in the synaptic cleft. To understand how
a-neurexins might function as synaptic organizers,
we solved the structure of the neurexin 1a extracel-
lular domain (n1a) to 2.65 A˚. The L-shaped molecule
can be divided into a flexible repeat I (LNS1-EGF-A-
LNS2), a rigid horseshoe-shaped repeat II (LNS3-
EGF-B-LNS4) with structural similarity to so-called
reelin repeats, and an extended repeat III (LNS5-
EGF-B-LNS6) with controlled flexibility. A 2.95 A˚
structure of n1a carrying splice insert SS#3 in LNS4
reveals that SS#3 protrudes as a loop and does not
alter the rigid arrangement of repeat II. The global
architecture imposed by conserved structural fea-
tures enables a-neurexins to recruit and organize
proteins in distinct and variable ways, influenced by
splicing, thereby promoting synaptic function.
INTRODUCTION
Neurexins are synaptic adhesion molecules recently implicated
in neuropsychiatric diseases, including autism spectrum
disorder (ASD) and schizophrenia (SZ) (Su¨dhof, 2008; Betancur
et al., 2009). Neurexins are located predominantly on the presyn-
aptic membrane. Their extracellular domains interact with
different proteins in the synaptic cleft, whereas their cytoplasmic
tails interact with the presynaptic exocytotic machinery. Neurex-
ins play a role in synapse maturation by fine-tuning synaptic
properties and regulate synaptic transmission through a ‘‘trans-
synaptic dialog’’ (Su¨dhof, 2008; Missler et al., 2003; Kattenstroth
et al., 2004; Zhang et al., 2005; Chubykin et al., 2007). When
levels of neurexin 1a (or its ligands neuroligins and LRRTMs)
are manipulated in animal models, excitatory and inhibitory
transmission is altered, a balance that is thought to be disruptedStructure 19in vivo in many neuropsychiatric diseases (Missler et al., 2003;
Kattenstroth et al., 2004; Levinson and El-Husseini, 2005; Varo-
queaux et al., 2006; Chubykin et al., 2007; Tabuchi et al., 2007;
Hines et al., 2008; Gibson et al., 2009; Etherton et al., 2009; de
Wit et al., 2009; Dahlhaus and El-Husseini, 2010; Blundell et al.,
2010). Manipulating levels of neurexins and their ligands in
animal models also replicates many of the behavioral alterations
seen in humans with ASD and SZ (Beglopoulos et al., 2005; Tab-
uchi et al., 2007; Hines et al., 2008; Jamain et al., 2008; Blundell
et al., 2009, 2010; Etherton et al., 2009; Dahlhaus and El-
Husseini, 2010). Neurexins and their protein partners are now
believed to be central components of a synaptic protein network,
which underlies a common biological pathway disrupted inmany
neuropsychiatric disorders (Guilmatre, 2009).
The extracellular domain of neurexin 1a (n1a) is composed of
three neurexin repeats (I, II, and III), which each contains the
modules LNS-EGF-LNS (Figure 1A). n1a binds endogenous
ligands including neuroligins, LRRTM family members, neurexo-
philin, a-dystroglycan, and GABAA receptors (Su¨dhof, 2008; Ko
et al., 2009a; de Wit et al., 2009; Zhang et al., 2010; Siddiqui
et al., 2010). a-Neurexins also regulate the functionality of certain
Ca2+ channels, though direct association has not been demon-
strated (Missler et al., 2003; Zhang et al., 2005). Recent studies
suggest that other, as yet unidentified, proteins interact with
a-neurexins as well (Ko et al., 2009b). Neurexins are structurally
and functionally diversified through alternative splicing of their
mRNAs (Figure 1A). Potentially, thousands of different neurexin
splice forms are produced with different protein partner-binding
profiles, generating a diverse portfolio of synaptic organizers.
n1a LNS domains contain two b sheets stacked as a b sandwich
in a jelly roll fold (Sheckler et al., 2006; Shen et al., 2008) (Fig-
ure 1A). A functional region called the ‘‘hypervariable surface’’
is formed by loops that carry splice inserts SS#2, SS#3, and
SS#4 and encompasses a Ca2+-binding site (experimentally
shown for L2, L4, and L6) (Rudenko et al., 1999; Sheckler
et al., 2006; Shen et al., 2008) (Figure 1A). Some, but not all,
protein partners interact with the ‘‘hypervariable surfaces.’’
Crystal structures show that neuroligins bind to the hypervari-
able surface of the LNS domain in n1b (identical to n1a L6) by
sandwiching the central Ca2+-binding site between the two
proteins (Arac¸ et al., 2007; Fabrichny et al., 2007; Chen et al.,
2008; Leone et al., 2010). LRRTM proteins compete with neuro-
ligins to bind n1b, suggesting that they share overlapping binding, 779–789, June 8, 2011 ª2011 Elsevier Ltd All rights reserved 779
Figure 1. n1a Structure
(A) In the left view, n1a is composed of six LNS or LG domains (laminin, neurexin, sex hormone-binding globulin, or lamininG domains) interspersed by three EGF-
like repeats. LNS domains are indicated as gray squares labeled L1–L6 and EGF-like repeats as black ovals labeled A, B, and C. In full-length n1a, L1 is preceded
by a signal peptide, and L6 is tethered to the cell membrane via a transmembrane segment (tms). Splice inserts SS#2, SS#3, and SS#4 add small stretches of
amino acids to L2, L4, and L6, respectively, whereas SS#1 inserts a stretch of residues between EGF-A and L2. Neurexin repeats I, II, and III are indicated. The
right view shows nomenclature of secondary structure elements in neurexin LNS domains using L2 as a template. The concave b sheet comprises b13, b2, b11,
b4, b5, b6, and b7. The convex b sheet comprises b1, b12, b3, b8, b9, and b10. The ‘‘hypervariable surface’’ surrounds a Ca2+-binding site (blue sphere) and
includes loops b2-b3, b4-b5, b6-b7, and b10-b11. Some LNS domains deviate from L2 by replacing a1 with a turn accommodated in a loop b12-b13 or have an
additional short b strand b14 following b13.
(B) Ribbon diagram of bovine n1a, domains L2–L6. b Strands in neurexin LNS domains are depicted as yellow arrows, a helices as yellow coils, loop b11-b12 is
shown in cyan, and the EGF-like repeats are in magenta. Themodule boundaries are as follows: L2 (Glu281–Thr485), L3 (Leu486–Cys679), EGF-B (Ser680–Glu722), L4
(Ala723–Ile909), L5 (Ile910–Cys1087), EGF-C (Glu1088–Gly1130), and L6 (Thr1131–Val1337). An N-linked oligosaccharide chain attached to Asn1230 is shown in ball-and-
stick representation (carbon atoms, white; nitrogen atoms, blue; oxygen atoms, red).
Structure
Neurexin 1a Extracellular Domainsites (Ko et al., 2009a; Siddiqui et al., 2010). a-Dystroglycan
binds the hypervariable surface of L2, and its association is dis-
rupted by destroying the Ca2+-binding site; a-dystroglycan also
binds to the hypervariable surface of L6 and is competed by
exogenous a-latrotoxin, another ligand for L6 (Sugita et al.,
2001). Single LNS domains can support ligand binding; binding
of some, but not all, protein partners is regulated by alternative
splice inserts and requires Ca2+.
Although isolated neurexin LNS domains have been exten-
sively characterized, high-resolution information on their ar-
rangement in the full-length n1a is not known, though a recent
study using electronmicroscopy (EM) has revealed a low-resolu-
tionmodel of n1a (Comoletti et al., 2010). The global organization
and conformational freedom between modules in the ectodo-
main of a-neurexins likely determine the ability of this family of
proteins to organize protein partners in the synaptic cleft. To
gain insight into n1a structure-function relationships, we solved780 Structure 19, 779–789, June 8, 2011 ª2011 Elsevier Ltd All rightsthe structure of bovine n1a by X-ray crystallography to a resolu-
tion of 2.65 A˚ and n1a+SS#3 to 2.95 A˚. The crystal structure of
n1a reveals an L-shaped molecule. The modules are tethered
together in flexible and rigid arrangements encoded by charac-
teristic structural features. Neurexin repeat I is flexible, repeat II
adopts a horseshoe-shaped structure similar to reelin repeats,
and repeat III adopts an extended arrangement with a putative
hinge between L5 and EGF-C. The architecture of n1a is highly
suited for a synaptic organizer that arranges different proteins
into large macromolecule complexes in order to promote
synaptic maturation and transmission efficiency.
RESULTS
Overall Shape of n1a
n1a (modules L1-L6, Leu31-.-Ser1339) is found as a monomer in
the crystal structure with an elongated L-shape (Figure 1B).reserved
Figure 2. Neurexin Repeat II (L3-EGF-B-L4)
(A) Variability of loop b11-b12 and loop b4-b5 in neurexin LNS domains. In amultiple structure alignment, the LNSmodules superimpose in a range of 1.09–1.37 A˚
for 177–194 Ca atoms (see Supplemental Experimental Procedures). Loop b11-b12 is shown in cyan for all modules, except L6 shown in blue. Loop b4-b5 is
shown in yellow for all modules, except L3 shown in red. The ‘‘concave’’ and ‘‘convex’’ b sheets are indicated.
(B) Ribbon diagram of the L3-EGF-B-L4 neurexin repeat II. Residues within 4 A˚ of each other forming the interfaces betweenmodules are shown in ball-and-stick
representation (carbon atoms, yellow, orange, cyan, or magenta; oxygen atoms, red; nitrogen atoms, blue; sulfur atoms, green). Loop b11-b12 is shown in cyan
and loop b4-b5 from L3 in orange. Molecular details are shown in the inset. The insertion site for SS#3 (G790-K800) is indicated in green. Direct contacts are formed
between L3 (primarily loop b4-b5 and loop b11-b12) and L4 (b2, loop b2-b3, b3, loop b4-b5, loop b6-b7, b8, loop b8-b9, loop b10-b11, b11, and loop b12-a1).
Hydrophobic and charged interactionsmediate the L3 and L4 interface. These include a hydrophobic cluster formed by Phe634, Trp639, Leu642, and Leu643 from L3
that packs against hydrophobic areas of Met742, Thr744, Glu745, Ala746, and Arg824 from L4, andmany charged residues, in particular salt bridges, between Asp536,
Arg848, Glu637, and Glu745 that ‘‘zig-zag’’ between L3 and L4, and a striking number of histidine residues His539, His743, His852, and His846. Direct contacts are
formed between EGF-B and L3 (loop b1-b2, loop b3-b4, loop b7-b8, loop b11-b12, and the b strands of the convex sheet b1, b3, and b12) and linker residues
connecting the twomodules. Direct contacts are formed between EGF-B and L4 (primarily b3, b8, b12, loop b12-a1, a1, loop a1-b13) and linker residues between
EGF-B and L4. Nomenclature is described in Figure 1A. Asp546 of loop b4-b5 in L3, a conserved counterpart of D772 in L4, is shown in ball-and-stick repre-
sentation.
(C) Ribbon diagram of the reelin repeat R6 containing modules L1, EGF, and L2 (PDB ID: 3A7Q; Yasui et al., 2010). L1 and L2 are shown in pink, EGF in magenta,
and the loop analogous to neurexin LNS domain loop b11-b12 is shown in cyan for both L1 and L2. The LA1 cysteine-rich repeat of the apoE receptor 2 binds to
the bottom of L1, shown in green. Calcium ions are shown as blue spheres. Reelin L2 corresponds structurally more to n1a L3, and reelin L1more to n1a L4 when
using the concave sheet filling loop b11-b12 to orient the modules.
Structure
Neurexin 1a Extracellular DomainContinuous electron density is visible for L2, L3, EGF-B, L4, L5,
EGF-C, and L6 (residues Glu281–Val1337), including interconnect-
ing residues. L2 through L5 form a long rod-shaped assembly
(the ‘‘back’’ of the ‘‘L’’). EGF-C and L6 form a shorter assembly
(the ‘‘foot’’ of the ‘‘L’’). The dimensions of the L2–L6 array
are 137 3 100 3 59 A˚. The two crystallographically indepen-
dent copies of n1a in the asymmetric unit (space group P1)
show an identical arrangement of modules (rmsd 0.295 A˚ for
1003 Ca pairs), suggesting that their molecular organization is
an intrinsic property. n1a appears increasingly flexible toward
its N terminus. L2 (Baverage 118.2 A˚
2) displays more thermal
motion than its C-terminal neighbors L3 (Baverage 83.2 A˚
2), L4
(Baverage 31.8 A˚
2), L5 (Baverage 26.9 A˚
2), and L6 (Baverage 68.9 A˚
2)
(as calculated by TLSANL) (CCP4, 1994). In addition, unlike for
the rest of the molecule, the electron density for L2 and the
concave b sheet of L3 largely does not resolve the individual
b strands, though it clearly reveals the b sheets. No electron
density is observed for L1 and EGF-A, though present in the
crystal, suggesting that these N-terminal modules are disor-
dered and can adopt multiple conformations. Thus, the crystal
structure of n1a reveals 7 out of 9 modules (1003 residues perStructure 19molecule) organized in an L-shaped assembly. Prior to exam-
ining the architecture of n1a, and its impact on n1a function,
the crystal contacts were analyzed (see Figure S1 and Supple-
mental Experimental Procedures available online).
Modules of n1a
The individual modules of n1a display striking structural features
that appear to have evolved tomaintain the global architecture of
the extracellular domain. First, though neurexin LNS domains
share a common jelly roll fold, characteristic loops extend from
their b sheets. Loop b11-b12 ranges from a short 10 residue
loop in L6 to a long 16 and 22 residue loop in L3 and L5 with
helical content, and fills the concave b sheet in different ways
(Figures 1B and 2A). Loop b4-b5 of the hypervariable surface is
quite short, just 4 to 6 residues, except in L3 where it spans 18
residues (Figure 2A). Second, in L2, L3, L4, and L5, but not the
terminal L6, a cysteine is located just before the polypeptide
chain continues on into the next module. These cysteine resi-
dues engage in a disulfide bond with a preceding cysteine
located on or near strand b12, one of the last strands in the
LNS domain fold (L2, Cys444-Cys480; L3, Cys650-Cys679; L4,, 779–789, June 8, 2011 ª2011 Elsevier Ltd All rights reserved 781
Figure 3. Neurexin Repeat III (L5-EGF-C-L6)
Residues within 4 A˚ of each other forming the interfaces between modules are
shown in ball-and-stick representation. L5 and L6 are shown in light yellow and
EGF-C in magenta. Loop b11-b12 is shown in cyan. Molecular details are
shown in the inset. EGF-C interacts with L6 by docking its C-terminal portion
against the center of the convex sheet of L6 (b3, b8, b9, b12), as well as in-
teracting with loop b7-b8, loop b9-b10, loop b12-a1, and the linker residues
between EGF-C and L6.
Structure
Neurexin 1a Extracellular DomainCys890-Cys898; L5, Cys1059-Cys1087). The disulfide bonds rigidly
define each module from the interconnecting linker residues
and module that follows. Third, the EGF-like repeats B and C
are structurally very similar to each other (1.0 A˚ rmsd for 35
matched Ca atoms), even though they share only 34% sequence
identity (13 out of 38 residues). EGF-B and C both consist of
two b strands and loops held together by three disulfide bonds
(connectivity C1-C3, C2-C4, and C5-C6). Their close structural
similarity suggests that these modules are compact, very well-
ordered domains that preserve their shape.
Organization of n1a
L2, L3, EGF-B, L4, and L5 form a rod-shaped array by packing
sequentially against each other via extensive interdomain inter-
actions. The b sandwiches of L2, L3, L4, and L5 arrange so that
the concave sheet of a preceding LNS domain interacts with
the convex sheet of the next LNS domain (Figure 1B). Loop
b11-b12 that fills the concave b sheet and in many structurally
related legume lectins forms part of a carbohydrate-binding site
(Loris, 2002), plays an important role in mediating interactions
between the concatenated LNS domains (Figures 1B and 2A).
Loop b11-b12 of L2 docks on L3 contacting central b strands of
its convex sheet (b3, b8) and the linker between L3 and EGF-B
(see Figure 1A for nomenclature). Loop b11-b12 of L3, in turn,
docks on central b strands of the convex b sheet of L4. Finally,
the base of loop b11-b12 of L4 docks on L5 contacting central
b strands of the convex sheet of L5, though this interface is
more complex and involves additional strands and loops of L4.
Remarkably, L6 breaks away from the rod-like assembly and
veers off at 75 angle mediated by EGF-C (Figure 1B).
Although the protein sequence of n1a can be divided into three
repeats (I, II, and III) (Figure 1A), the spatial organizations of these
repeats are dramatically different. The L1-EGF-A-L2 repeat
appears flexible because L1 and EGF-A are not visible in the
crystal structure. L3-EGF-B-L4 adopts a globular horseshoe-
shaped structure, and L5-EGF-C-L6 forms an extended array.
The compact EGF-like repeats play a crucial role in determining
the different structural arrangements of the neurexin repeats and
the overall shape of the n1a.
In L3-EGF-B-L4, EGF-B spans the top of the LNS domain pair
providing extensive interactions to both (Figure 2B, details in
legend and summarized below). EGF-B interacts with loops con-
necting the convex and concave sheets of L3, and b strands from
the convex b sheet of L3. EGF-B contacts b strands from the
convex b sheet of L4, loop b12-b13 that contains helix a1, and
the linker between EGF-B and L4. At the bottom of the L3–L4
array, the long loop b4-b5 that is present only in L3 (refer to Fig-
ure 2A) arcs over and binds to the ‘‘hypervariable surface’’ of L4.
Lys538 at the tip of this loop interacts with the side chain of Asp772
(loop b4-b5) and the backbone carbonyl of Leu789 (loop b6-b7),
two key residues of the Ca2+-binding site in L4 (Figure 2B).
This site not only binds Ca2+ ions but also competing positively
charged amino groups (Shen et al., 2008). Remarkably, L3-
EGF-B-L4 resembles the jelly roll-EGF-jelly roll arrangement
found in so-called ‘‘reelin repeats’’ of reelin (Figure 2C), a protein
that directs neuronal migration during cortical development and
is implicated in neuropsychiatric disorders (Knuesel, 2010; Yasui
et al., 2010). Furthermore, the reelin repeat R6 binds the LA1
module of one of its receptors, the apoE receptor 2, by exploiting782 Structure 19, 779–789, June 8, 2011 ª2011 Elsevier Ltd All rightsa binding site that coincides structurally with the hypervariable
surface of L4 (Figure 2C).
In L5-EGF-C-L6, EGF-C separates L5 from L6 (Figure 3).
EGF-C interacts with L5 in a fundamentally different way
compared to L6, suggesting that a structural mechanism has
evolved to support neurexin function. EGF-C docks onto the
terminal residues of the L5 polypeptide chain (Glu1084 from
strand b14, Gly1086, and its final residue Cys1087). A very short
‘‘hinge’’ connects L5 and EGF-C (Glu1088–Gly1089). The bulky
side chains Arg1085 and Trp1109 pack on one side of the hinge,
and Glu1084 and Lys917 (that form a salt bridge together) as well
as Pro1090 pack on the other side (Figure 3). These residues likely
limit the conformational freedomof the hinge. The hinge is further
delineated by residues on either side in the polypeptide
sequence: Cys1087-Glu1088-Gly1089-Pro1090-Ser1091. At one
end, the disulfide bond between Cys1087 and Cys1059 covalently
restricts motion. At the other end, Pro1090 restricts the polypep-
tide backbone conformational freedom through its covalent
interaction with main-chain atoms, whereas Ser1091 and subse-
quent residues are buried in EGF-C. L6 makes no direct interac-
tions with L5 or the rest of the molecule, other than with the
preceding EGF-C. Unlike the interaction between L5 and
EGF-C, the interaction between EGF-C and L6 is extensive, sug-
gesting that the orientation between EGF-C and L6 is fixed (Fig-
ure 3). The hinge in neurexin repeat III suggests that the ‘‘foot’’ of
the L-shape (EGF-C-L6) can pivot with respect to the ‘‘back’’ of
the L-shape (L2–L5), though the range of motion is likely limited
by the residues that pack on either side of the hinge.n1a+SS#3
The remarkable horseshoe-shaped arrangement of L3-EGF-
B-L4 and its similarity to reelin repeats prompted further investi-
gation. The extra-long loop b4-b5 from L3 that extends its tip intoreserved
Figure 4. Structure of n1a+SS#3
(A) Superposition of neurexin repeat II (L3-EGF-B-L4) without SS#3 (in gray) and carrying SS#3 (in yellow andmagenta). For the latter, SS#3 is shown in green with
missing residues represented by dotted lines, and loop b4-b5 is shown in red. For clarity the neurexin repeat is rotated 180 with respect to Figure 2B.
(B) SigmaA-weighted 2Fo-Fc electron density map in the region surrounding the splice insert SS#3, contoured at 0.9 s for molecule 1 (left) and molecule 2 (right).
In n1a lacking SS#3, Asp790 is replaced by Gly790, and covalently connected to Lys800. Two residues have poor side-chain density and have been built as alanine
residues (Ile794 and Lys800).
(C) SS#3 (Asp790-Ile794, green carbon atoms) inserts between Leu789 and Lys800 and does not displace b4–b5 of L3 (orange carbon atoms). Residues are shown in
ball-and-stick-representation with color scheme: oxygen, red; nitrogen, blue; and sulfur, yellow.
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Neurexin 1a Extracellular Domainthe Ca2+-binding site of L4 also docks close to the insertion site
for splice insert SS#3 (for which no function is known yet). To
answer the question if SS#3, which replaces Gly790 with a ten
amino acid splice insert Asp790-Ser799 (refer to Figures 1A
and 2B), changes the domain organization of L3-EGF-B-L4, we
solved the structure of n1a+SS#3 to a resolution of 2.95 A˚. L3-
EGF-B-L4 with and without SS#3 superimposes within 0.27 A˚
for 414 Ca atoms, indicating that SS#3 does not alter the
arrangement of the modules (Figure 4A). Both SS#3 as well as
loop b6-b7 that host the splice insert are clearly visible in the
electron density with the exception of a gap corresponding to
Cys796-Asn797-Ser798-Ser799 of SS#3 (Figure 4B; Figure S2).
SS#3 extends loop b6-b7 out into solution. A salt bridge forms
between Arg793 of SS#3 and Asp845 of loop b10-b11 (Figure 4C).
Cys791 and Cys796 of SS#3 do not engage in a disulfide bridge.
The presence of SS#3 does not rearrange the Ca2+-binding
site of L4 significantly (i.e., the side chain of Asp772 and the back-
bone carbonyls of Arg848 and Leu789, the latter that is directly
adjacent to the splice insert site). Strikingly, the presence of
SS#3 does not prevent loop b4-b5 of L3 from binding to the
hypervariable surface of L4, and Lys538 is again found blocking
the Ca2+-binding site of L4 (Figure 4C). This suggests that the
organization of repeat II is an intrinsic property of n1a that is
tied to a-neurexin function.
DISCUSSION
Structure-Function Relationships of n1a
The remarkable shape of n1a is produced by interplay between
structural elements within individual modules and interactions
between modules leading to neurexin repeats with very different
conformational arrangements and freedoms. The striking struc-
tural features that promote this architecture also suggest that the
global organization of a-neurexins is fundamentally important for
their function as synaptic organizers.
Before evaluating potential structure-function relationships,
we assessed whether the crystal structure likely reflects the
conformation of n1a in the synaptic cleft.Structure 19Does neurexin repeat II form a rigid core? L3-EGF-B-L4 forms
the largest intramolecular interface in n1a, burying 2893.3 A˚2
(1386 A˚2 between L3 and L4, 870 A˚2 between L3 and EGF-B,
and 637 A˚2 between EGF-B and L4). SS#3 does not disturb
the organization of this repeat nor does it prevent loop b4-b5
of L3 from inserting into the hypervariable surface of L4. All
mammalian a-neurexin genes share this long loop b4-b5 in L3,
and a lysine or arginine residue is found at position Lys538 in 14
mammalian n1a and n3a sequences, though ambiguous
sequence alignments prevent an analogous residue from being
identified in n2a. Reelin repeats show a similar spatial arrange-
ment to neurexin repeat II, though they are further assembled
into rod-shaped, linear assemblies, unlike n1a (Figure 2C)
(Nogi et al., 2006; Yasui et al., 2007). Both n1a neurexin repeat
II and reelin repeat R6 use a lysine residue at the hypervariable
surface (or its structural counterpart) to interact with a protein
surface. In n1a, Lys538 interacts with Asp772 of L4, likely stabi-
lizing neurexin repeat II. In reelin repeat R6, a lysine residue
from jelly roll L1 interacts with a protein partner (LA1 of the
apoE receptor 2) via aspartate residues surrounding the LA1
Ca2+-binding site (Yasui et al., 2010) (Figure 2C). The situation
is not completely analogous because in n1a, Lys538 blocks the
Ca2+-binding site of L4, whereas in reelin, Lys2467 likely requires
the Ca2+ ion in LA1 to arrange the acidic residue cluster for inter-
action (Yasui et al., 2010). Nonetheless, the extensive buried
surface, the conserved key structural features, undisturbed
even by SS#3, and the structural similarity to reelin repeats all
suggest that the horseshoe-shaped conformation of L3-EGF-
B-L4 is an intrinsic property of the n1a architecture.
Does EGF-C keep L5 and L6 separated at a discrete distance?
Although the interface between EGF-C and L6 (990 A˚2) is smaller
than that buried in the L3-EGF-B-L4 horseshoe, EGF-C likely
packs solidly against L6. Its buried surface is on the same scale
as that between L2 and L3 (994 A˚2), L4 and L5 (1107 A˚2), the
direct interaction between L3 and L4 (1386 A˚2), and the interac-
tion site between reelin R6 and apoE receptor 2 LA1 (700 A˚2)
with a reported affinity of100 nM (Yasui et al., 2010) (Figure 2C).
In contrast the buried surface between L5 and EGF-C is much, 779–789, June 8, 2011 ª2011 Elsevier Ltd All rights reserved 783
Figure 5. Protein-Partner Recognition by n1a
(A) The hypervariable surfaces of L2, L3, L4, L5, and L6 align on one side of n1a (loops shown in light orange). Conserved residues Asp329 (L2), Asp546 (L3), Asp772
(L4), Asp958 (L5), and Asp1183 (L6) central to each hypervariable surface (and in L2, L4, and L6 can ligand Ca2+) are shown in ball-and-stick representation with
distances indicated. Insertion sites for splice insert SS#2, SS#3, and SS#4 are indicated with yellow, green, andmagenta spheres, respectively. The loop b4-b5 of
L3 is shown in dark orange. Possible mechanisms by which n1a (L1–L6) recognizes different protein partners (‘‘p1’’–‘‘p6’’) are shown in (B)–(D). Variability
introduced by alternative splice inserts is shown for L2, L4, and L6 with carets.
(B) Single LNS domains could interact with different protein partners using splice insert-dependent and/or -independent mechanisms.
(C) Combinations of two LNS domains could bind protein partners potentially influenced by a splice insert.
(D) Multiple modules of n1a could bind a protein partner potentially influenced by one or more splice inserts.
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Neurexin 1a Extracellular Domainsmaller (289 A˚2). Key structural features are identical in almost all
22 sequences from mammalian a-neurexin genes 1, 2, and 3,
namely: the hinge residues (Glu1088 and Gly1089), stretches of
seven residues N and C terminal to the hinge, and the bulky
side chains that pack spatially around the hinge. This suggests
that neurexin repeat III enables the rigid EGF-C-L6 assembly to
pivot with respect to the rest of the molecule to some (limited)
extent.
Are the buried surfaces between modules in the n1a L2–L6
assembly true biological interfaces? Except for one, all the inter-
faces classify as relatively small biological interfaces (or very
large crystal contacts) (see Supplemental Experimental Proce-
dures). However, current methodologies do not accurately
discriminate biological interfaces from fortuitous crystal
contacts in crystal structures of proteins containing covalently
connected modules, like n1a, because the steric and entropic
contributions imparted by linking modules are not accounted
for. Analysis of 22 mammalian a-neurexin sequences shows
that almost 80% of all interface residues are either conserved
or semiconserved, and of these 75% of the Tyr, His, Phe,
Trp, Leu, Ile, Val, Met, and Arg residues (residues that are often
found at biological contacts; Lo Conte et al., 1999). Therefore,
whereas the sizes of the buried surfaces between modules in
n1a do not unambiguously prove that these interfaces exist in
solution, they are large enough and share high enough sequence
conservation to indicate they form and that the organization of
n1a in the crystal structure likely represents a physiologically
relevant conformation.
The shape of n1a shows similarities with molecular envelopes
of n1a produced recently by EM. n1a was visualized as
a Y-shape. L1–L4 were assigned to the long base of the Y,
whereas L5–L6 were assigned to the two arms of the Y (Como-
letti et al., 2010). Two regions of flexibility were pinpointed: one
between EGF-A and L2, and a second between L5 and L6. The
resolution of the EM data did not permit the orientation of the
LNS domains to be determined or the position of the EGF-like784 Structure 19, 779–789, June 8, 2011 ª2011 Elsevier Ltd All rightsrepeats, thereby limiting further comparison. Nevertheless, the
global architecture of n1a, i.e., an elongated molecule with L6
veering spatially away from the L2–L5 array, is consistent
between the EM and crystallographic studies suggesting that it
is a physiological feature.
Functional Consequences of the n1a Architecture
The domain arrangement of n1a has fundamental consequences
for a-neurexin function. The hypervariable surfaces of L2, L3, L4,
L5, and L6 line up on one side of the molecule (Figure 5A).
Because these surfaces are putative binding sites for protein
partners (discussed in the Introduction), interacting ligands
would assemble on just one side of the extracellular domain,
a feature that would facilitate presynaptically tethered n1a to
recruit multiple partners exposed on the opposing postsynaptic
membrane. The n1a arrangement also suggests that multiple
modes of protein-partner recognition are possible. Ligands inter-
acting with different single LNS domains could be recruited
simultaneously by a-neurexins and spatially organized into large
macromolecular complexes in the synaptic cleft (Figure 5B).
Protein partners might also interact with two LNS domains (Fig-
ure 5C). Although it is not known how multiple domains of n1a
might interact with a-dystroglycan, the structurally related lami-
nin a2 LG4-LG5 tandem binds a-dystroglycan using surfaces
that surround a Ca2+-binding site on each module, analogous
to the Ca2+-binding sites found at neurexin hypervariable
surfaces. Although the two LG domains adopt a fixed V-shape
not seen in n1a, their arrangement constrains the putative a-dys-
troglycan binding surfaces to the same side of the molecule at
the tips of the V (Tisi et al., 2000). Likewise, a protein partner in-
teracting with neurexin L2 and L3, or L3 and L4, would subject
itself to the spatial constraints imposed by n1a. In contrast,
proteins interacting with L1 and L2, or L5 and L6, would either
need to be flexible themselves or rigid molecules that imposed
their own molecular architecture on n1a. Finally, large protein
partners might contact more than two adjacent or nonadjacentreserved
Figure 6. Molecular Modeling of the Interaction between n1a
and NL1
The NL1 dimer (blue) is shown with an n1a molecule (coloring scheme as in
Figure 5A) bound to each subunit. On the left the n1a:NL1 interaction is dis-
played as a ribbon diagram with key structural features labeled. On the right
the n1a:NL1 interaction is shown as a ribbon diagram covered by a solvent-
accessible surface. Site A in NL1 is indicated by two red spheres connected by
a dotted line and Site B by a single, red sphere. Splice insert sites SS#2, SS#3,
and SS#4 in n1a are indicated by yellow, green, and magenta spheres,
respectively. The putative hinge between L5 and EGF-C is indicated. A dotted
double-headed arrow depicts potential movement of the L2–L5 assembly with
respect to EGF-C-L6 controlled by the hinge.
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modulate protein-partner binding and recognition (Figure 5D).
Molecular recognition would be influenced by the rigid and flex-
ible connections within the n1a architecture. The relatively large
distances between the splice insert sites (>26 A˚) and the rela-
tively short stretches of polypeptide added (<30 aa) suggest
that it is unlikely that splice inserts or insert sites end up directly
side by side each other. However, a portfolio of different
composite binding sites could be formed (like mosaics made
up of varying pieces) as a function of the different splice inserts
present or absent (Figure 5D).
With the different binding modes in mind, we modeled the
interaction between n1a and neuroligin 1 (NL1) using the struc-
ture of the n1b:NL1 complex as a guide (Arac¸ et al., 2007;
Chen et al., 2008). Like neurexins, the family of postsynaptic
adhesion molecules, neuroligins, is diversified through alterna-
tive splicing at a Site A (which can carry inserts of 20 aa) and
in NL1 also at a Site B (that can carry an insert of9 aa) (Su¨dhof,
2008). Although n1a appears to bind NL2 preferentially over NL1,
NL3, or NL4 (Kang et al., 2008; suggested by Chih et al., 2006),
subsequent reports have shown that n1a also binds NL1 if the
Site B insert is absent (Boucard et al., 2005; Ko et al., 2009a;
Siddiqui et al., 2010; Comoletti et al., 2010; Reissner et al.,
2008). Superimposition of n1a L6 on the identical domain of
n1b of the n1b:NL1 complex reveals the spatial location of the
n1a-specific modules with respect to NL1. The docking studies
show that when L6 binds NL1, EGF-C functions as a spacer,
placing the L2–L5 assembly alongside each NL1 subunit of the
dimer (Figure 6). In the n1a:NL1 model, Site B of NL1 is close
to the interface between L6 and NL1, and Site A of NL1 in close
to L3 and L4 (Figure 6). The hinge between L5 and EGF-C would
permit optimal alignment of L3 and/or L4 with NL1. Therefore,
our docking studies suggest that it is possible for Site B in NL1
to cooperate with SS#4 of L6 in n1a (as it does in n1b) (Arac¸Structure 19et al., 2007; Chen et al., 2008) following the concept of a splice
code centered around Site B and SS#4 that governs the interac-
tions between neurexins and neuroligins (Su¨dhof, 2008). In addi-
tion it is possible that Site A in neuroligins cooperates with SS#3
of L4. If true, interaction between Site B and SS#4 would consti-
tute one part of the splice code, and Site A and SS#3 another for
regulating binding between a-neurexins and neuroligins.
Our model of the n1a:NL1 complex is consistent with
biochemical data describing the interaction of n1a with different
partners, such as neuroligins and a-latrotoxin.
Neuroligins
Because L6 protrudes as an isolated domain from n1a extending
its hypervariable surface out to the solvent (Figures 1B and 6), it
is likely that the binding mode between n1b and neuroligins is
largely preserved in the interactions between L6 of n1a and neu-
roligins. n1b and NL1 splice forms bind each other with nanomo-
lar affinity (in the range of 10–95 nM [Comoletti et al., 2006; Arac¸
et al., 2007; Chen et al., 2008; Siddiqui et al., 2010], thoughmuch
weaker affinities have been reported [Koehnke et al., 2010]). For
b-neurexins, binding is weakest when the Site B insert and SS#4
are present simultaneously, and binding between b-neurexins
and neuroligins is not affected by Site A (Boucard et al., 2005;
Ko et al., 2009a; Siddiqui et al., 2010). However, for a-neurexins,
SS#4 in n1a reduces binding to NL1, as it does for n1b, but the
Site B insert in NL1 completely disrupts binding to n1a, unlike
to n1b (Boucard et al., 2005; Ko et al., 2009a; Reissner et al.,
2008; Siddiqui et al., 2010). Furthermore, Site A seems to
promote binding between n1a and NL1 (Boucard et al., 2005),
a curious result given the large distance between Site A and
the L6:neuroligin interface. The n1a crystal structure suggests
the following insights. First, Site B is located at the L6:neuroligin
interface, near the hinge between L5 and EGF-C (Figure 6). The B
Site insert, which also carries an N-linked glycosylation site,
likely produces steric hindrance when brought in proximity with
the n1a-specific L2–L5 assembly. Indeed, enzymatic deglycosy-
lation of NL1 (A+, B+) largely restores its binding to n1a, and this
activation through deglycosylation requires the Site B insert to
be present (Boucard et al., 2005). Site B and its N-linked glyco-
sylation site are believed to be functionally important because
deletion of this glycosylation site shifts NL1 (A+, B+ N303A) to
GABAergic synapses (Chih et al., 2006), potentially because
binding to n1a splice forms at inhibitory synapses is now more
viable. Second, our n1a:NL1 model suggests that n1a-specific
modules can interact with Site A, explaining why it modulates
a-neurexin binding but not b-neurexin binding. Although Site B
has received much attention, Site A is biologically important as
well. The presence of Site A inserts in NL1 (-B) and NL2 (not
spliced at B) shifts these neuroligins from excitatory synapses
to inhibitory synapses (Chih et al., 2006), though it must now
be demonstrated that this is due to n1a-specific interactions
and not other interacting proteins. Finally, a-neurexin-specific
modules were shown to reduce binding to neuroligins, at least
for the combinations of splice forms tested so far. Deletionmuta-
genesis pinpointed L3-EGF-B-L4 as the main suppressor of
n1a:NL2 interaction compared to n1b-mediated binding (Kang
et al., 2008). If n1a were a linear concatenation of modules, as
often depicted in the literature, these results would be difficult
to explain. However, our n1a:NL1 model predicts that modules, 779–789, June 8, 2011 ª2011 Elsevier Ltd All rights reserved 785
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the extracellular domain is not linear, and L3 and/or L4 may
interact directly with neuroligins (regulated by the combination
of Site A and SS#3).
a-Latrotoxin
a- and b-neurexins bind a-latrotoxin in a Ca2+-dependent
manner via L6. a-Latrotoxin binds n1a with low nanomolar
affinity, competes prebound a-dystroglycan off, and the pres-
ence of SS#4 in n1a and n1b disrupts its binding (Davletov
et al., 1995; Sugita et al., 1999). At low-salt concentration
(100 mM), n1b-SS#4 binds a-latrotoxin as well as n1a
(+SS#1/-SS#2/+SS#3/-SS#4) (Sugita et al., 1999). However,
the interaction between a-latrotoxin and n1b does not withstand
a high-salt concentration, unlike n1a, which still binds a-latro-
toxin at unusually high-salt concentrations (1.5 M NaCl) (Sugita
et al., 1999). This strongly suggests that the interaction between
n1b (or n1a L6) and a-latrotoxin is predominantly governed by
electrostatic interactions, whereas additional interactions must
be present in n1a that contribute hydrophobic surfaces to the
interaction site with a-latrotoxin. Our n1a model suggests that
not only L6 but also modules N terminal to L6 could interact
directly with a-latrotoxin because the mobility of the L5-EGF-C
hinge and the spacer role of EGF-C would provide them access.
Therefore, whereas binding of n1a to neuroligins and a-latro-
toxin could be described by model Figure 5D, binding to other
protein partners, e.g., neurexophilin binding to L2 (Missler
et al., 1998) and LRRTM proteins that seem to bind n1a and
n1b similarly well (Siddiqui et al., 2010; de Wit et al., 2009; Ko
et al., 2009a), might be better described by model Figure 5B.
Future Directions
The n1a architecture likely impacts how many of the different
a-neurexin protein partners are recruited and organized. Like-
wise, protein-partner binding may impact the conformation of
n1a, underscoring the importance of determining structures
of n1a in complex with different ligands. The crystal structure
of n1a suggests that the modules preceding L6 may regulate
the interaction of ligands bound to L6 (positively or negatively).
This must now be experimentally addressed. Given that a-neu-
rexins are increasingly implicated in neuropsychiatric diseases,
it is fascinating to speculate that their lesion destroys the spatial
organization of an array of synaptic proteins that are functional
on their own but must be properly assembled into large macro-
molecular complexes to release their full potential. The strategi-
cally positioned structural elements of n1a and a protein-partner
profile that can be regulated by different splice inserts distributed
along its length suggest that a-neurexins are extremely well
suited to function as scaffolding molecules in the synaptic cleft
and that a-neurexins may host a diverse set of protein interac-
tions, some of which might even be targeted therapeutically in
the future with small molecule compounds.
EXPERIMENTAL PROCEDURES
Protein Expression and Purification
The extracellular domain of bovine neurexin1a (called n1a, nm_174404) was
expressed in insect cells. n1a contains residues Met1-Ser1339, including the
endogenous signal peptide, but not SS#1, SS#2, SS#3, or SS#4, though786 Structure 19, 779–789, June 8, 2011 ª2011 Elsevier Ltd All rightsthey are accommodated in the numbering scheme. Crystals of mutant
n1a_N190Q (no splice inserts) diffracted past 2.65 A˚. Crystals of n1a+SS#3,
identical to n1a but containing SS#3 (DCIRINCNSS), diffract similarly to n1a
without the optimizing N190Q mutation. n1a was also expressed as a seleno-
methionyl form replacing 19 out of 22methionines permolecule on average, as
determined by mass spectrometry.
Protein Crystallization
Crystals of n1a (native andselenomethionyl forms), n1a_N190Q, andn1a+SS#3
grow in a broad range of conditions containing 5%–10% Peg 8000 or Peg
10000, 100mMBicine (pH 8.0–9.0), 2.5mMCaCl2 at 20
C, andwere harvested
under similar conditions containing 5 mMCaCl2 and flash cooled with glycerol.
All four proteins produce crystals with space group P1 and similar cell dimen-
sions (for n1a_N190Q, a = 60.953 A˚, b = 114.543 A˚, c = 159.58 A˚, a = 90.61,
b = 90.87, and g = 92.18) that are radiation sensitive and diffract weakly.
Structure Determination
n1a was solved by a combination of molecular replacement and single anom-
alous dispersion (SAD) techniques using Phaser (McCoy et al., 2007). Briefly,
the selenomethionyl n1a data to 4 A˚ were used to iteratively place 8 out of
12 possible LNS domains. Model phases generated from the partial molecular
packing were then used by Phaser to locate 37 out of 44 possible selenium (Se)
atoms producing a phase set with figure of merit (fom) 0.507–4 A˚. Subsequent
rounds of model building and refinement with REFMAC (Murshudov et al.,
1997) generated an improved model that enabled additional Se atoms to be
located by Phaser. In total, 42 potential Se sites were refined with SHARP (Bri-
cogne et al., 2003) using the best availablemodel phases as an external source
of phase information, and they produced a phase set with fom 0.678–3.26 A˚.
The model was completed and refined to 2.65 A˚ with the n1a_N190Q data
set. Of the 40 ordered methionine residues in the n1a molecules, 39 match
a Se atom position. Difference Fourier analysis suggests that only L2 may
contain a Ca2+ ion. The model of n1a has a MolProbity score (Chen et al.,
2010) of 2.78 (66th percentile) and a clashscore of 16.45 (84th percentile);
92.2% of the residues are in the favored region of the Ramachandran plot,
and 1.6% of the residues are in the unfavorable region. n1a+SS#3 was solved
by molecular replacement with Phaser using the n1a monomer as a search
model (and, as a control, single LNS domains). Themodel of n1a+SS#3 refined
to 2.95 A˚ has a MolProbity score of 3.25 (54th percentile) and a clashscore of
25.82 (85th percentile); 89.9% of the residues are in the favored region of the
Ramachandran plot, and 1.8% of the residues are in the unfavorable region.
Model Analysis
The contact analysis was carried out using PDBePISA (www.ebi.ac.uk/
msd-srv/prot_int/pistart.html; Krissinel and Henrick, 2007).
Details of the structure determinations are summarized in Table 1, and addi-
tional details are provided in the Supplemental Experimental Procedures.
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Table 1. Data and Refinement Statistics Summary for n1a_N190Q, SMet-n1a and n1a+SS#3
Crystal n1a_N190Q SMet-n1a n1a+SS#3
Data Statistics
Space group P1 P1 P1
Resolution (A˚)a 39.9–2.65 (2.70–2.65) 35.0–3.25 (3.31–3.25) 48.51–2.95 (3.00–2.95)
Reflections total/unique 418,903/124,701 267276/67601 306,149/89,668
Multiplicity 3.4 4.0 3.4
Completeness (%) 98.5 (98.2) 98.6 (97.9) 98.4 (95.6)
Rmerge (%)
b 7.9 (52.6) 13.5 (80.2) 9.0 (53.2)
I/s 17.8 (3.0) 14.6 (1.9) 14.1 (2.1)
Fom from Phaser (8 LNS domains + 37 Se atoms) to 4.0 A˚: 0.507
Fom from SHARP (model + 42 Se atoms) to 3.26 A˚: 0.678
Refinement Statistics
Resolution (all reflections jFj/sR 0.0) 30.0–2.65 A˚ 30.0–2.95 A˚
Protein atoms (including carbohydrate) 15,440 15522
Protein residues 2,006 (23 1003) 2,016 (23 1,008)
Solvent atoms 0 0
Molecules in the asymmetric unit 2 2
Unique reflections 123,177 89,495
Working set/test setc 116,726/6,451 84,841/4,654
Rwork 20.82% 20.83%
Rfree 22.96% 23.54%
Rmsd bond lengths 0.018 A˚ 0.026 A˚
Rmsd bond angles 1.730 2.335
Rmsd NCS-related molecules (Ca atoms) 0.295 A˚ (1,003) 0.203 A˚ (1,008)
Total Bave/residual Bave (atomsmainchain)
d 65.3 A˚2/47.2 A˚2 (8,024) 91.7 A˚2/79.4 A˚2 (8,064)
Total Bave/residual Bave (atomssidechain)
d 65.7 A˚2/47.9 A˚2 (7,360) 92.4 A˚2/79.8 A˚2 (7,402)
aOuter shell statistics in parentheses.
bRmerge = S (j(I  < I >)j/S (I).
c Test set for n1a+SS#3 constructed using reflections present in the n1a test set to avoid bias.
d Total Bave reported by TLSANL/residual Bave reported after TLS and positional refinement by REFMAC.
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Note Added in Proof
In this issue, Miller et al. report the structure of the extracellular domain of neu-
rexin 1a L2-L6 under Ca2+-free conditions carrying splice insert SS#3. The
overall arrangement of the domains in the structure is similar to the n1a L1-
L6 structures with andwithout SS#3 that we report here under Ca2+-containingStructure 19conditions, though structural differences are seen in splice insert SS#3 and the
loop b4-b5 in L3. Also, under our experimental conditions, only L2 shows clear
evidence of a Ca2+-ion bound.
The studies differ in the extent of the interpretations. Our study supports
a scenario whereby both L6 and N-terminal domains, including L4, approach
neuroligin. Thus, the presence or absence of SS#3 in L4 and a splice insert at
site A in neuroligins may together determine the affinity of neurexin1a:NL1-
binding. This suggests that for a-neurexins the neurexin:neuroligin splice
code encompasses not only SS#4 and site B , but also SS#3 and site A. We
also believe that further experimental data are required to predict the orienta-
tion of the L2-L5 array in the synaptic cleft, because the neurexin 1a ectodo-
main likely flexes at hinge L5-EGF-C to accommodate different protein
partners bound to the two ends of the molecule. During preparation of these
proofs, Tanaka et al. (2011, PLoS One 6(4):e19411) published the structure
of L5-EGF-C-L6 that, though showing a similar packing between EGF-C and
L6, shows a dramatic motion of L5 with respect to EGF-C compared with
our structures, confirming the flexibility of the L5-EGF-C hinge., 779–789, June 8, 2011 ª2011 Elsevier Ltd All rights reserved 789
